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Abstract
The current study extended the literature by examining whether three profiles of depression
predicted breast cancer status. In 1,076 women of the Baltimore Epidemiologic Catchment Area
Study, depression status and hopelessness were measured at baseline and breast cancer status
was ascertained 24 years later. Double depression, but not major depression or dysthmia, was
associated with breast cancer. Hopelessness predicted fewer new cases of breast cancer. When
double depression and hopelessness were simultaneously entered as predictors, the regression
weights of both predictors increased. The role of severe and extended duration depression as
well as possible explanations for unexpected findings are discussed.

Keywords
major depression; dysthymia; chronic depression; hopelessness; breast cancer; longitudinal
design

3

Introduction
Breast cancer has been identified as one of the most prevalent and deadly forms of
cancer. According to the American Cancer Society (2014) statistics regarding cancer, breast
cancer is projected to rank first in the development of new cases and second in death in 2014.
Given the large-scale impact of breast cancer, psychological phenomena related to the illness
development and trajectory have been explored. One particular psychological contribution that
has been studied in the literature is depressive symptoms (for a meta-analysis see Pössel et al.,
2012).
The relationship between depressive symptoms and breast cancer was described as
noteworthy as early as 1893 (Snow, 1893) and several biobehavioral theories have posited
explanations for this association. First, the relationship between depressive symptoms and breast
cancer may be due to compromised immune functioning. More specifically, depressive
symptoms negatively affect immune functioning and in turn, impaired immune functioning
increases susceptibility to breast cancer (Ader et al., 1995). Associations between depression
and the production of pro-inflammatory cytokines support such theory. For example, studies
have revealed elevated levels of IL-6 in individuals who are depressed, as compared to
individuals who are not depressed (Kop and Gottdiener, 2005; Pizzi et al., 2008). Second, the
relationship between depressive symptoms and breast cancer may result from a dysregulation in
the release of cortisol by the hypothalamic-pituitary-adrenal-axis (HPA-axis). Because cortisol
plays an influential role in cell growth and activity, disruption (i.e., flattening of the diurnal
cortisol rhythm) of the release of cortisol throughout the day will likely increase the risk of
cancer. This hypothesis is supported by studies showing that flattened diurnal cortisol patterns
throughout the day are associated with an increase in the risk of breast cancer (Pulaski et al.,
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2005; Su et al., 2005; Ticher et al., 1996). Further, research has shown that greater levels of
depressive symptoms are associated with elevated IL-6 and flatter diurnal cortisol rhythms
(Sjögren et al., 2006a; Sjögren et al., 2006b). While multiple theories and studies reveal insight
into why the relationship between depressive symptoms and breast cancer may exist, limited
research has explored how the conceptualization of depression may influence or contribute to
this association.
A recent meta-analysis (Pössel et al., 2012) revealed that 12 of 15 prospective studies
reported a positive association between depressive symptoms at baseline and a later diagnosis of
breast cancer. While the estimated overall correlation r = +0.025 +/- 0.027 (95% confidence
interval) was not significant, the meta-analysis demonstrates that the time frame is of crucial
importance. To be more precise, while only 70% of the studies using inappropriate short time
frames between the assessment of depressive symptoms and the development of breast cancer (<
18 years) found a positive association between both variables, 100% of the studies with
appropriate long time frame found such association (Pössel et al., 2012). Research conducted by
Gross, Gallo, and Eaton (2010) revealed that a longer duration, but less severe episode, of
depressive symptoms is associated with an increased risk of breast cancer. Specifically, this
particular study revealed that while major depression (minimum duration 2 weeks, greater
severity) did not significantly predict breast cancer incidence and mortality, the relationship
between dysthymia (minimum duration 2 years, less severity) and breast cancer was significant.
Additional research found that individuals reporting depressive symptoms at three time points
across six years were more likely to experience breast cancer than an individual who was
experiencing depressive symptoms at two or fewer time points (Penninx et al., 1998). Thus, one
could propose that the duration of depression is critical for the development and trajectory of
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breast cancer. However, findings of a recent study revealed marginally significant associations
between the number of depressive symptoms and breast cancer incidence and mortality (p = .06;
Gross et al., 2010). Studies have also supported a relationship between greater symptoms of
cancer, such as pain or fatigue, and greater severity of depressed mood (Bower et al., 2000;
Spiegel et al., 1994). Further, a reduction in depressive symptoms has been associated with a
longer survival rate in breast cancer patients (Giese-Davis et al., 2011). Thus, it seems that the
severity of depressive symptoms may be a factor of consideration in the strength of the
relationship between depressive symptoms and breast cancer. While no study to depression and
breast cancer incidence and mortality considered a combined effect of both duration and severity
of depression, a longitudinal study exploring the effect of depression on risk of breast cancer
hospitalization did (Jacobs and Bovasso, 2000). The authors of this study found that both
duration and severity of depression were important in contributing to a significant relationship
between depression and increased risk of breast cancer hospitalization, as compared to only
duration or severity. A combined effect of duration and severity of depression, defined as double
depression for the purposes of this study, makes sense considering that both duration and
severity (Sjögren et al., 2006a; Sjögren et al., 2006b) of depression are associated with
significant changes in the immune system.
Finally, research suggests that there may be an association between hopelessness and
breast cancer incidence (Eskelinen and Ollonen, 2011). Although hopelessness often occurs with
severe episodes of depression (Brown and Harris, 1978), it is not recognized as a symptom of
depression in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5; American
Psychiatric Association, 2013) and two prominent models in the literature consider hopelessness
a risk factor, rather than a symptom, of depression (Abramson et al., 1989; Beck, 1976).
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Additionally, studies have noted the distinct and important role of hopelessness in the
relationship between depressive symptoms and the above mentioned biological risk factors of
breast cancer IL-6 and cortisol. For example, hopelessness is - mediated through depressive
symptoms - associated with diurnal cortisol rhythm (Pössel et al., 2015) and hopelessness is
associated with IL-6, even when controlling for depressive symptoms (Mitchell et al., 2013).
Thus, it may be the case that hopelessness is the “active” ingredient in the relationship between
depression and breast cancer.
One purpose of the study was to evaluate whether the number of depressive symptoms,
the chronicity of the symptoms, or a combination of severity and duration of symptoms (i.e.,
double depression) predict breast cancer incidence and mortality. The severity hypothesis
predicts that major depressive disorder and double depression, but not dysthymia, would be
significantly associated with breast cancer status. The duration hypothesis predicts that
dysthymia and double depression, but not major depressive disorder, would be significantly
associated with breast cancer status. The combined hypothesis predicts that only double
depression, but not dysthymia and major depressive disorder, would be significantly associated
with breast cancer status. Based on the existing literature to depressive symptoms and breast
cancer (Gross et al., 2010; Jacobs and Bovasso, 2000; Penninx et al., 1998) as well as to
depression and immune system (Sjögren et al., 2006a; Sjögren et al., 2006b) it was predicted that
the combined hypothesis would be confirmed.
The second purpose of the study was to examine whether hopelessness (not part of the
DSM symptom criteria but nevertheless independently predictive of important outcomes such as
suicide; Kuo et al., 2004) and depressive symptoms differentially relate to breast cancer
incidence and mortality. The hopelessness hypothesis predicts hopelessness and depression
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would be independently associated with breast cancer status. But the relationship of depressive
disorder with breast cancer status would be significantly reduced when controlling for
hopelessness, whereas the relationship between hopelessness and breast cancer status would not
be influenced by depression. Again, based on the research described above (Eskelinen and
Ollonen, 2011; Mitchell et al., 2013; Pössel et al., 2015) it was predicted that the hopelessness
hypothesis would be confirmed.
Method
Participants
The Baltimore Epidemiologic Catchment Area (ECA) Study is a 24-year longitudinal
study in which psychopathology and physical health in the general adult population are
measured. The baseline assessment took place in 1981 and the most recent follow-up
assessments occurred in 2004 and 2005. At baseline, adults aged 18 years and older were
sampled probabilistically from the population residing in households in Eastern Baltimore. As
breast cancer is about 100-times more common in women than in men (American Cancer
Society, 2014), the analyses in this study focus exclusively on women. Protocols of the
Baltimore ECA Program were reviewed and approved by the Committee on Human Research of
the Johns Hopkins Bloomberg School of Public Health. Further, the procedures were in
accordance with the Helsinki Declaration. Informed consent was obtained from each participant
prior to their inclusion in the study.
Materials
Diagnostic Interview Schedule (DIS). Depression status at baseline was measured using the
DIS (Robins et al., 1981). The DIS is a standardized interview which includes questions that
provide information about the appropriateness of Diagnostic and Statistical Manual of Mental
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Disorders (DSM)-III diagnoses of mental disorders based on symptoms and co-occurrence of
symptoms in time. Information about major depressive disorder and dysphoria was available at
the symptom level and a computerized algorithm was used to construct DSM-III diagnoses. The
DIS has been found to be a conservative measure of depressive disorder when compared to a
psychiatrist’s examination (Eaton et al., 2000). For the present study, respondents were
separated into four mutually exclusive groups: Participants with (a) double depression (both
diagnoses of major depression and dysthymia), (b) major depressive disorder, (c) dysthymia, or
(d) neither double depression, major depression, or dysthymia at baseline.
Hopelessness. As hopelessness is not part of depression based on the DSM (APA, 2013), no
item in the depression section of the DIS measures for hopelessness. Instead, hopelessness at
baseline was assessed using the question, “Has there ever been a period of time when you felt
that life was hopeless?” from the somatization section of the DIS (Robins et al., 1981).
Participants responded “yes” or “no” to the question.
Breast Cancer Incidence and Mortality. Breast cancer incidence and mortality were collapsed
to define breast cancer status. Information was ascertained through participants’ self-report
during the 24-year follow-up interviews or the National Death Index (NDI) through 2007.
Breast cancer was considered present if it was either the primary or a contributing cause of death
on a death certificate. Year of breast cancer onset was determined during the 24-year follow-up
interviews by asking about the year of the first breast cancer diagnosis for those who reported
having breast cancer. Time of breast cancer diagnosis was not available for cancers ascertained
through the NDI. First time diagnosis dates were used to exclude participants that reported
having breast cancer before baseline.
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Covariates. All variables considered as covariates were selected based on a priori theory (Gallo
et al., 2000; Gross et al., 2010). Age, self-reported race/ethnicity, smoking status, and
socioeconomic status (SES) were considered as possible covariates in the analyses. As in
previous studies testing for associations between depression and cancer using The Baltimore
Epidemiologic Catchment Area (ECA) Study sample (Gross et al., 2010), smoking status at 24year follow-up was coded into one of four groups: never smoked (0), stopped smoking (1),
currently smoking less than one pack of cigarettes per day (2), and currently smoking more than
one pack per day (3). SES at baseline was represented by a composite score aggregating
occupational status, annual household income level, and highest level of education completed
(Gallo et al., 2000). To identity their race/ethnicity, participants could choose between American
Indian (n = 23; 2.1%), Asian (n = 4; 0.4%), Pacific Islander (n = 2; 0.2%), Black (n = 402;
37.4%), Hispanic (n = 9; 0.8%), and White (n = 636; 59.1%; code = 1). Because of the low
number of most minority groups, all racial/ethnic minority groups were collapsed into one
category (n = 440; 40.9%; code = 2).
Data Analysis
To evaluate the duration, severity, and combined hypotheses, three Cox proportional
hazards regression models were conducted with breast cancer status as the dependent variable
and with depression status as independent variable: one model with dysthymia vs. no dysthymia
as the predictor, one model with major depression vs. no major depression as the predictor, and
one model with double depression vs. no double depression as the predictor. The severity
hypothesis would be classified as correct when major depression and double depression, but not
dysthymia, significantly predict breast cancer status. The duration hypothesis would be
classified as correct when dysthymia and double depression, but not major depression,
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significantly predict breast cancer status. The combined hypothesis would be classified as
correct when double depression, but not dysthymia and major depression, significantly predict
breast cancer status.
To evaluate the hopelessness hypothesis, one additional Cox proportional hazards
regression model with hopelessness vs. no hopelessness as the predictor and a paired t-test were
calculated. The t-test was conducted to evaluate the regression coefficients from the significant
models with one predictor (depression status or hopelessness) to the model with both predictors
(depression status and hopelessness). This hypothesis would be classified as correct when a)
hopelessness and depression status both significantly predict breast cancer status when not
controlling for each other; b) the regression coefficient of depression status, but not
hopelessness, is significantly reduced in the model with both predictors (depression status and
hopelessness) compared to the models with one predictor (depression status or hopelessness).
Results
The Baltimore ECA cohort sample at baseline consisted of 1,945 women and complete
data for depression status and hopelessness at baseline as well as breast cancer status 24 years
later exist for 1,076 of these women (55.32% of the baseline population). Participants that
reported to have been diagnosed with breast cancer before the baseline interviews (n = 6) were
excluded from the data analyses. Thus, 1,070 women, ranging from age 19 to 87 years (mean
age = 43.91 years, SD = 17.17) at baseline, remained in the analysis sample. The participants
that remained in the analysis sample, compared to participants excluded from further analyses,
were not significantly different with regard to race/ethnicity (χ2(1)=0.42; p = .516), hopelessness
(χ2(1)=0.30; p = .585), dysthymia (χ2(1)=0.70; p = .404), major depression (χ2(1)=1.36; p =
.243), or double depression (χ2(1)=1.71; p = .191) at baseline. However, participants that
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dropped out were significantly older than the ones that remained in the analysis sample
(t(2068.10) = 12.66, p < .001).
Within the analysis sample, at baseline 22 women fulfilled the criteria of dysthymia, 42
women fulfilled the criteria of major depression, and 10 women fulfilled the criteria of double
depression at baseline. Thus, 996 women did not fulfill the criteria of any depression diagnosis
at baseline. Further, 208 women answered that they had felt hopeless and 862 answered they did
not feel hopeless in the baseline interview. Finally, within the analysis sample, 43 women were
diagnosed for the first time with breast cancer between 1981 and 2005 and/or died with breast
cancer being either the primary or a contributing cause of death. Of the women with dysthymia,
major depression, and double depression at baseline 4.8%, 4.8%, and 20%, respectively, were
diagnosed for the first time with breast cancer between 1981 and 2005 and/or died with breast
cancer being either the primary or a contributing cause of death. Of the women without any
depression diagnosis at baseline 3.5% were diagnosed for the first time with breast cancer
between 1981 and 2005 and/or died with breast cancer being either the primary or a contributing
cause of death.
Age, self-reported race/ethnicity, smoking status, and SES were considered as possible
covariates in the analyses. Because of concerns about over-fitting models due to low counts of
breast cancer incidents, smoking status and SES were dropped as covariates as they did not
significantly correlate with any of the depression variables, hopelessness, or breast cancer status
(Table 1). Like expected, age and race/ethnicity were positively related with breast cancer
status. Thus, higher age and racial/ethnical minority status were associated with a higher
likelihood of breast cancer.
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To test the duration, severity, and combined hypotheses three Cox proportional hazards
regression models adjusting for age and race/ethnicity were conducted. Consistent with the
combined hypothesis, only double depression (p = .018) but not dysthymia (p = .903) or major
depression (p = .685) at baseline predicted breast cancer status at the 24 year follow up (Table 2).
These analyses demonstrated that double depression at baseline was associated with more breast
cancer incidents and mortality within the next 24 years.
To test the hopelessness hypothesis two additional regression analyses were calculated.
Contrary to the hypothesis, the regression with only hopelessness revealed that hopelessness at
baseline significantly predicted fewer new cases of breast cancer and mortality in the following
24 years (p = .043; Table 2). Moreover, the adjusted Cox model that included both double
depression and hopelessness as predictors of breast cancer status revealed that double depression
(p = .005) and the absence of hopelessness at baseline (p = .026) remained significantly
associated with breast cancer status in the following 24 years (Table 2). Finally, paired t-tests
comparing the regression weights in the Cox models with only one predictor (double depression
or hopelessness) with the regression weights in the Cox models with both predictors (double
depression and hopelessness) were calculated. The tests revealed that the regression weights of
double depression (t(1060) = 2.96; p = .003) and hopelessness (t(1060) = 22.02; p < .001) were
actually significantly increased when adjusting for each other (Table 2).1
Discussion
Breast cancer status significantly associated with both depressive symptoms and
hopelessness. Follow-up analyses examining the associations separated for breast cancer

1

This pattern of findings is identical when only breast cancer incidents were used as dependent variable. When only
breast cancer mortality was used as dependent variable, neither depression nor hopelessness were significant
predictors.
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incidents and mortality demonstrated that breast cancer incidents, but not mortality, were
significantly associated with both depressive symptoms and hopelessness. As expected and
consistent with the combined hypothesis, but contrary to the expectations regarding the duration
and severity hypotheses, only double depression at baseline predicted an increase of breast
cancer incidents in the following 24 years. While this finding may seem inconsistent with
previous studies to breast cancer which found effects of duration (Gross et al., 2010; Penninx et
al., 1998) or severity (Gross et al., 2010) of depression on breast cancer incidents and mortality,
neither of the previous analyses tested for a combined effect of duration and severity. However,
a longitudinal study exploring the multiplicative effect of duration and severity of depression on
risk of breast cancer hospitalization (Jacobs et al., 2000) found that both were important in
contributing to a significant relationship between depression and increased risk of breast cancer
hospitalization, as compared to only duration or severity. Thus, the findings of the present study
extend support for the role of the combined effect of severity and duration of depressive
symptoms on breast cancer incidents, consistent with prior research on other breast cancer
outcomes.
Regarding the hopelessness hypothesis, the analyses revealed two surprising findings.
First, hopelessness at baseline was expected to be associated with more breast cancer incidents
and higher mortality rate in the next 24 years. Instead, hopelessness is associated with fewer
breast cancer incidents and not with mortality at all. Second, when controlled for each other, the
strengths of the associations of double depression and hopelessness with new cases of breast
cancer increased instead of becoming weaker as predicted.
Based on the findings from the current study, it may be that hopelessness is associated
with less participation in breast cancer screenings, thus resulting in less breast cancer incidents
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reported. Research examining hopelessness and breast cancer screening beliefs in 382 women
revealed that women who expressed hope for the future were more likely to endorse motivation
to engage in breast cancer screenings. Further, women with greater hope for the future reported
more benefits and less barriers to the screening process (Çam et al., 2009). Thus, it is likely that
greater hopelessness may be associated with less motivation and greater barriers to the breast
cancer screening process, resulting in less breast cancer incidents reported. While this
interpretation may explain why hopelessness was associated with fewer new breast cancer
incidents, it remains unclear why hopelessness was not associated with breast cancer mortality as
one would expect less breast cancer screening is associated with later discovered cases of breast
cancer and therefore a higher likelihood of breast cancer mortality (for a discussion of the
benefits of breast cancer screening see Gøtzsche and Jørgensen, 2013). Women who do not
participate in breast cancer screenings have been found to have a higher mortality rate than
women who participate in screenings (Nyström et al., 1993). However, it may be that other
factors associated with breast cancer screening participation, such as knowledge or beliefs about
breast cancer screenings or treatment (Magai et al., 2007), play a more significant role in
mortality as an outcome, as compared to hopelessness. Future research should examine the
association between hopelessness and participation in breast cancer screenings, as well as other
known predictors of breast cancer screening participation and mortality, to better understand how
these constructs operate together.
The study findings highlight the importance of depression screening in clinical care,
particularly considering both depression severity and duration, for the prevention of future breast
cancer incidents and mortality. While the prevalence of double depression is low, cases of
double depression are associated with poor social and physical functioning across an extended
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period of time (Rhebergen et al., 2010) and poor quality of life (Rapaport et al., 2005). Thus, it
is likely that treatment services of double depression will improve quality of life and reduce
economic costs associated with such mental health concerns. In sum, for the purposes of the
current study, screening and treatment of patients with double depression may be an effective
method of reducing future breast cancer incidence and prevention.
The results of the study should be viewed with consideration of the limitations.
Hopelessness was evaluated using only one item. However, the item is comprised of the larger
and comprehensive Diagnostic Interview Schedule (DIS; Robins et al., 1981), which has shown
acceptable reliability and validity scores (Robins et al., 1981). Additionally, as described in
other articles, one limitation associated with the ECA sample is drop-out during follow-up (see
Eaton et al., 2008; Gross et al., 2010). Further, results were not adjusted for other factors that
have been associated with breast cancer incidence, such as stress (Chida et al., 2008) or physical
activity (Monninkhof et al., 2007). Finally, it needs to be considered that only a relatively small
number of women fulfilled the diagnostic criteria of dysthymia (n = 22), major depression (n =
42), and double depression (n = 10) at baseline. Thus, while the ECA has crucial strengths,
including a large representative population-based sample, an extended follow-up, and the usage
of a structured interview to assess depression and hopelessness future research should replicate
the present study using a multi–item instrument to measure hopelessness, measuring and
controlling for more potential confounding variables, and oversampling women with dysthymia,
major depression, and double depression.
In summary, the current study revealed that double depression, but not dysthymia and
major depression, was positively associated with breast cancer at the 24-year follow-up; whereas,
hopelessness was negatively associated with breast cancer in the next 24 years. Thus, not
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severity or duration of a depressive disorder but a combination of both is crucial for the
association of depression with breast cancer in the following 24 years. Future research should
measure the duration and severity of depression as continuous variables and include participation
in breast cancer screening and expression of negative emotional experiences as additional
variables to replicate and explore possible explanations for the findings of the present study.
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